Mouse Model – DLBCL/FL

Gain access to our mouse models in FL/DLBCL, including vavP-BCL2 strain, KMT2D-flox CD19-cre strain and BTG1-KO strain (and more). These models enable to investigate novel drug targets and test for drug efficacy and toxicity

Mouse Model

Explore our available mouse models (drug resistant, immuno-competent, or immuno-deficient strains) to investigate lymphoma biology and identify novel drug targets.

Mouse Model – Eµ-myc

We provide Eµ-myc mouse model for non-Hodgkin B cell lymphoma study, characterized for response to chemotherapies and to metabolic inhibitors, metabolomic (carbon tracing), and transcriptomic.

In vitro modelisation – Naïve B cells to plasma cell differentiation

We offer an in vitro model of B-cell terminal differentiation, based on the isolation and activation of donor-derived B-cells. This system allows functional studies of specific proteins through gene expression modulation with antisense technology and is fully characterized by immunoglobulin isoform analysis.

Mouse Model for lymphoid neoplasms – DLBCL

Explore our mouse models designed respectively for the study of DLBCL, Burkitt Lymphoma, Amyloid light-chain amylosis, Multiple Myeloma, or Fanconi Syndrom, Light and heavy chain deposition disease. These models enable the identification of novel therapeutic targets as well as the evaluation of drug efficacy and toxicity.

In vitro modelisation – Memory B cells to plasma cell differentiation

Explore our in vitro model enabling the isolation of memory B cells from blood donors and their differentiation into plasma cells. This system supports the study of protein function through gene expression modulation or drug treatment and is extensively characterized at a molecular and epigenetic levels.

Nous contacter